「GSK-3β」の版間の差分

ナビゲーションに移動 検索に移動
編集の要約なし
編集の要約なし
編集の要約なし
23行目: 23行目:
[[Akt]]
[[Akt]]
</pre><pre>&lt;references /&gt;</pre>
</pre><pre>&lt;references /&gt;</pre>
1. '''Stambolic V, Woodgett JR'''
1. '''Stambolic V, Woodgett JR'''  


Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation.  
Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation.  
29行目: 29行目:
''Biochem. J: ''1994, 303 (pt 3); 701-4 [PubMed: 7980435]  
''Biochem. J: ''1994, 303 (pt 3); 701-4 [PubMed: 7980435]  


'''2. Wood-Kaczmar A, Kraus M, Ishiguro K, Philpott KL, Gordon-Weeks PR.''''''<br>'''An alternatively spliced form of glycogen synthase kinase-3beta is targeted to growing neurites and growth cones.<br>
'''''2. Wood-Kaczmar A, Kraus M, Ishiguro K, Philpott KL, Gordon-Weeks PR.'''''
An alternatively spliced form of glycogen synthase kinase-3beta is targeted to growing neurites and growth cones.


Mol Cell Neurosci.: 2009, 42 (3);&nbsp;184-94 [PMID: 19607922]&nbsp;
''Mol Cell Neurosci.: ''2009, 42 (3);&nbsp;184-94 [PMID: 19607922]&nbsp;  


3.
3.
71

回編集

案内メニュー